Krittanawong, Chayakrit
Saw, Jacqueline
Olin, Jeffrey W
Article History
First Online: 11 August 2020
Compliance with Ethical Standards
:
: Dr. Chayakrit Krittanawong discloses the following relationships: Journal of the American Heart Association (Editorial board); European Heart Journal Digital Health (Editorial board); The Journal of Scientific Innovation in Medicine (Associate Editor); The Lancet Digital Health (Advisory board); The American College of Cardiology Solution Set Oversight Committee. Dr. Saw has received unrestricted research grant supports (from the Canadian Institutes of Health Research, Heart & Stroke Foundation of Canada, National Institutes of Health, AstraZeneca, Abbott Vascular, St Jude Medical, Boston Scientific, and Servier), salary support (Michael Smith Foundation for Health Research), speaker honoraria (AstraZeneca, Abbott Vascular, Boston Scientific, Bayer), consultancy and advisory board honoraria (AstraZeneca, Boston Scientific, Abbott Vascular, Gore, Baylis, and Abiomed), and proctorship honoraria (Abbott Vascular and Boston Scientific). Dr. Olin is the Chair of the Medical Advisory Board of the Fibromuscular Dyspasia Society of America; the Chair of the Steering Committee and Principal Investigator for the United States Registry for Fibromuscular Dysplasia; and the investigators for the iSCAD registry.
: This article does not contain any studies with human or animal subjects performed by any of the authors.